She
had a sparkling British accent and spoke crisply. Her responses to me
were sprinkled with “brilliant” and “lovely.” She told me, “Now that
first proof of concept” has been established, the next wave of mRNA
products is coming down the pipeline with over $50 billion market share
this year.
She
is a representative of Hanson Wade, a company producing the 3rd Annual
mRNA-Based Therapeutics Summit (“Supercharging the Next Wave of
efficacious mRNA Therapeutics & Vaccines). Her job is “curating the
audience for the upcoming 3rd mRNA-Based Therapeutics Summit this July.”
She was calling me because I requested information about the summit and
provided my contact details as requested.
She
wanted to spend 15 minutes speaking with me about my interest in the
conference and my role in mRNA development. I pleaded off the phone
interview (my calendar is jammed today) and requested printed materials.
Shortly after, I received a multi-paged PDF brochure3 for the
conference, which is on the pricey side at $6100 for the Conference plus
workshop day for Service and Solution Provider Pricing. Academic,
Research Institutes, and Not for Profit pricing was set at $4346 for the
same package.
Her
follow-up email said, “From Moderna’s first In-Africa clinical trial of
mRNA HIV vaccine to Merck’s use of messenger-RNA technology to fight
cancer, the mRNA space is showing real promise in showing that it is
being applied to other applications beyond COVID-19…I would be keen to
discuss how your company is involved in the mRNA space and whether your
work is focused on mRNA application to new disease areas and
indications. What time works for you tomorrow for a quick 15-minute
call?”
NIH Director Confirms Nanoparticle In-Human Tests As
an aside, I quickly looked up HIV mRNA vaccines and found “The
Director’s Blog” for NIH reporting on the first-in-human tests. The
acting Director of NIH, Lawrence A. Tabak, DDS, Ph.D., said:
“This
nanoparticle, administered by injection, is designed to mimic a small,
highly conserved segment of an HIV protein that allows the virus to bind
and infect human cells. In the body, those nanoparticles launch an
immune response and then quickly vanish. But because this important
protein target for HIV vaccines is so tiny, its signal needed
amplification for immune system detection.
“To
boost the signal, the researchers started with a bacterial protein
called lumazine synthase (LumSyn). It forms the scaffold, or structural
support, of the self-assembling nanoparticle. Then,
they added to the LumSyn scaffold 60 copies of the key HIV protein.
This louder HIV signal is tailored to draw out and engage those very
specific B cells with the potential to produce bnAbs. [emphasis added]
“As
the first-in-human study showed, the nanoparticle vaccine was safe when
administered twice to each participant eight weeks apart.”
Please
note the section I have emphasized where the Director of NIH excitedly
reports that the vaccine contains a bacterial protein that “forms a scaffold, or structural support, of the self-assembling nanoparticle.” WHAT??
Is
this the same self-assembling kind of nanotechnology many have denied
exists in vaccines? The kind of nanotechnology that Dr. Ana Maria
Mihalcea, MD, Ph.D., has been researching and exposing along with dozens
of other scientists and physicians around the world. Why yes, it is
that kind of technology. Now admitted to exist by the Director of NIH,
and also by the Office of the President of the United States in the
newly released National Nanotechnology Initiative. So, mystery over. There is nanotechnology in the shots…that is what the mRNA platforms get loaded with!
Calling All Investigators
But
back to my conversation with the curator of the upcoming mRNA summit.
She had asked me if I could speak with her tomorrow. I don’t know if I
have the time for that chat. But I need to share the 35-page brochure
that I was sent so that some of our colleagues and investigative
journalists can begin to help citizens understand the implications of
the mRNA industry. The mRNA industry is here, whether we are prepared or
not.
As the brochure says: “The mRNA revolution is here! Stretching beyond COVID-19 vaccines, the field has exploded with 800+ mRNA drugs currently in development and the acceleration of novel mRNA platforms into unchartered disease areas.” [emphasis added]
We
called for the complete ban on mRNA products and platforms in January
2023.7 In December 2022; we identified the pre-COVID pandemic meeting
that revealed that the hopeful mRNA vaccine industry wanted to “blow the
system up” so that they could open the vaccine industry floodgates to
mRNA-based products. Continuing Reading and Access Endnotes.
Find us at Twitter: @WeAreThePrey @GingerBreggin Find us at our website: www.Breggin.com Find us at www.AmericaOutLoud.com Find us on Substack at: Peter and Ginger Breggin Exposing the Global Predators
First published on AmericaOutLoud.com.
Primary
author Ginger Ross Breggin. She and her husband, Peter R. Breggin MD,
are the authors of the bestselling new book "COVID-19 and the Global
Predators: We are the Prey," with introductions by top COVID-19
scientists and physicians, Peter A. McCullough MD, MPH; Elizabeth Lee
Vliet MD; and Vladimir “Zev” Zelenko MD. Over 120,000 sold.
| 
No comments:
Post a Comment